Paper Details 
Original Abstract of the Article :
Sunitinib is a tyrosine kinase inhibitor approved for the treatment of renal cell carcinoma (RCC). Few data evaluated severe buccodental adverse events. The aim of this study was to evaluate sunitinib buccodental toxicity in patients with metastatic RCC and to compare it with that of standard chemot...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790170/

データ提供:米国国立医学図書館(NLM)

Sunitinib: A Cancer Drug with Potential Buccodental Side Effects

The fight against cancer is a long and arduous journey through a vast and unforgiving desert. This study investigates the potential side effects of sunitinib, a tyrosine kinase inhibitor used to treat renal cell carcinoma (RCC), on the oral cavity. It's like checking for hidden dangers along the path, ensuring that the treatment doesn't cause unnecessary harm.

Sunitinib and Buccodental Toxicity

The researchers found that sunitinib can cause severe buccodental toxicity, leading to problems like mouth sores and gum disease. These findings highlight the importance of careful monitoring for oral complications in patients receiving sunitinib.

Managing Potential Oral Side Effects

Knowing the potential for oral side effects from sunitinib is like knowing about the dangers of a treacherous sandstorm in the desert. It allows us to take preventative measures and provide appropriate treatment if necessary. This study emphasizes the importance of comprehensive oral care for patients receiving this medication.

Dr.Camel's Conclusion

This study provides valuable information about the potential for buccodental side effects from sunitinib. It reminds us that the fight against cancer requires a holistic approach, taking into account the potential impact of treatment on different parts of the body. This knowledge empowers us to provide better care for our patients, ensuring that they receive the best possible treatment while minimizing potential side effects.

Date :
  1. Date Completed 2013-12-04
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

24045668

DOI: Digital Object Identifier

PMC3790170

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.